While 2016 was marked by a changing landscape as the city’s tech community expanded into new neighborhoods, 2017 was defined by moves from the companies themselves.
In a buyout that marks the latest endorsement for targeted cancer drugs—and, potentially, the increasing utility of broad cancer DNA tests—Roche this morning agreed to acquire San Diego biotech Ignyta in an all-cash deal valued at $1.7 billion.
Sisu is hiring in Baltimore and Ghana. Sisu is a medical device company for emerging markets and these hires will play an integral role as we launch Hemafuse in Ghana and Kenya. Hemafuse is a device that can salvage and recycle a person’s own blood from internal bleeding. Sisu is seeking a baltimore-based Program Manager and Production Manager (posting soon). We are also hiring a Ghana-based Marketing manager and Africa-based Sales director. Click on the blog post to see more!
Application deadlines:
JANUARY 15, 2018 for New Applications
FEBRUARY 5, 2018 for Re-submissions
APRIL 5, 2018 for Grant Submission
As part of your application, you will need to complete and upload a one page abstract as well as upload your curriculum vitae (CV). Please download the abstract guidelines and provide your abstract in the requested format. You will be able to upload additional supporting documents once your application has been submitted by following the link that will arrive in your confirmation email.
Life sciences are booming with over 10M SF lab space, Shady Grove is producing a modest mini-city, and the Purple Line is revving its engines!
Come learn about market trends and developments in Shady Grove, Silver Spring, Rockville Pike, Germantown, Gaithersburg, and the Life Sciences Corridor.
Sign up today to take part in what promises to be a fun, exciting, and influential morning. Gain invaluable information and enjoy networking with your friends and colleagues in the industry.
Bacteriophages, or simply phages, are viruses that infect and replicate within bacteria, and they hold considerable potential for combatting antibiotic-resistance and other threats to human health. Timed with the hundredth anniversary of their discovery, a new review published in the British Journal of Pharmacology examines the challenges and opportunities of developing phages as health-promoting, commercially-viable biopharmaceuticals.
2017 has undoubtedly been a standout year in the realms of telemedicine and digital health.
In telehealth alone, much has happened over the past 12 months.
My glowing genes, Rudolph!
If we didn’t already know that Rudolph the Red-Nosed Reindeer was special, that shiny proboscis of his could have resulted from the one-in-a-million transfer of genetic material from a brilliant colored coral found in the Red Sea.
Swiss drugmaker Roche has won fresh approvals for two cancer drugs in Europe and the United States, shoring up its position in new medicines as it braces for falling sales of older products.
Vicki Sato, a longtime Boston biotech entrepreneur, laid out a challenge for New York life sciences in 2018. “Stop being an initiative,” she said. “Start being a player.”